Phenylephrine postconditioning increases myocardial injury: Are alpha-1 sympathomimetic agonist cardioprotective? | Zendy

Iordanis Mourouzis | Zendy; Theodosios Saranteas | Zendy; Heidi Ligeret | Zendy; Christophe Portal | Zendy; P. Périmenis | Zendy; Constantinos Pantos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Phenylephrine postconditioning increases myocardial injury: Are alpha-1 sympathomimetic agonist cardioprotective?

Author(s) -

Iordanis Mourouzis,

Theodosios Saranteas,

Heidi Ligeret,

Christophe Portal,

P. Périmenis,

Constantinos Pantos

Publication year - 2014

Publication title -

annals of cardiac anaesthesia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.42

H-Index - 27

eISSN - 0974-5181

pISSN - 0971-9784

DOI - 10.4103/0971-9784.135850

Subject(s) - medicine , phenylephrine , lactate dehydrogenase , p38 mitogen activated protein kinases , protein kinase b , endocrinology , protein kinase a , agonist , cardioprotection , reperfusion injury , kinase , mapk/erk pathway , ischemia , apoptosis , pharmacology , receptor , chemistry , enzyme , biochemistry , blood pressure

We studied effects of phenylephrine (PHE) on postischemic functional recovery and myocardial injury in an ischemia-reperfusion (I-R) experimental model.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research